Pacira BioSciences (PCRX) Stock Chart & Stock Price History $19.80 -0.03 (-0.15%) (As of 10:57 AM ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Pacira BioSciences Stock Price Performance 5 Day Performance-0.30%1 Month Performance+18.99%3 Month Performance+35.15%6 Month Performance-29.76%Year-To-Date Performance-41.32%1 Year Performance-35.82% Receive PCRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Pacira BioSciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Do this Before Elon’s Reveal on January 22nd (Ad)Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.I urge you to watch this video now. PCRX Stock Chart for Wednesday, December, 18, 2024 PCRX Chart by TradingView Pacira BioSciences Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/17/2024$19.87$19.83-0.20%$20.01$19.33690,329 shs$915.61 million12/16/2024$19.86$19.87+0.05%$20.27$19.14702,910 shs$917.40 million12/13/2024$19.80$19.86+0.30%$19.91$18.73605,475 shs$916.94 million12/12/2024$20.33$19.80-2.61%$20.42$19.76600,373 shs$914.17 million12/11/2024$19.76$20.33+2.88%$20.40$19.40681,026 shs$938.64 million12/10/2024$19.09$19.76+3.51%$19.85$18.76836,108 shs$912.32 million Get the Latest News and Ratings for PCRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pacira BioSciences and its competitors with MarketBeat's FREE daily newsletter. 12/09/2024$19.27$19.09-0.93%$19.81$18.82949,767 shs$881.39 million12/06/2024$18.67$19.27+3.21%$19.40$18.671.59 million shs$889.70 million12/05/2024$19.09$18.67-2.20%$19.54$18.541.15 million shs$861.99 million12/04/2024$16.68$19.09+14.45%$19.49$16.641.66 million shs$881.44 million12/03/2024$17.81$16.68-6.34%$17.94$16.411.42 million shs$770.12 million12/02/2024$16.91$17.81+5.32%$17.86$16.78589,186 shs$822.29 million11/29/2024$16.64$16.91+1.62%$17.01$16.47296,431 shs$780.74 million11/28/2024$16.64$16.64$17.00$16.53487,708 shs$768.27 million11/27/2024$16.78$16.64-0.83%$16.99$16.53487,708 shs$768.27 million11/26/2024$17.42$16.78-3.67%$17.34$16.29475,098 shs$774.73 million11/25/2024$17.55$17.42-0.74%$18.09$17.41532,332 shs$804.28 million11/22/2024$17.38$17.55+0.98%$17.78$17.24495,169 shs$810.34 million11/21/2024$17.03$17.38+2.06%$17.55$17.02397,614 shs$802.44 million11/20/2024$16.73$17.03+1.79%$17.26$16.58466,592 shs$786.28 million11/19/2024$16.64$16.73+0.54%$16.91$16.46917,944 shs$772.42 million11/18/2024$16.60$16.64+0.24%$16.82$16.10621,759 shs$768.32 million Related Companies Supernus Pharmaceuticals Stock Chart Omeros Stock Chart Nektar Therapeutics Stock Chart Assembly Biosciences Stock Chart Cumberland Pharmaceuticals Stock Chart Eli Lilly and Company Stock Chart Johnson & Johnson Stock Chart AbbVie Stock Chart Merck & Co., Inc. Stock Chart Pfizer Stock Chart Receive PCRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Pacira BioSciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PCRX) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pacira BioSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pacira BioSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
